News
$Pluri Inc (PLUR.US)$ Pluri Introduces Groundbreaking Immune Cell Expansion Technology, Secures New US Patent
Benzinga· 1 min ago
Leading biotechnology company, Pluri Inc. (NASDAQ:PLUR) (TASE:PLUR) ("Pluri" or the "Company"), which transforms cells into solutions that promote global wellbeing and sustainability, today unveiled a novel method for expansion of immune cells using proprietary technology and announced it was granted a new U.S. patent titled, "System and Methods for Immune Cells Expansion and Activation in Large Scale."
Benzinga· 1 min ago
Leading biotechnology company, Pluri Inc. (NASDAQ:PLUR) (TASE:PLUR) ("Pluri" or the "Company"), which transforms cells into solutions that promote global wellbeing and sustainability, today unveiled a novel method for expansion of immune cells using proprietary technology and announced it was granted a new U.S. patent titled, "System and Methods for Immune Cells Expansion and Activation in Large Scale."
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
